Advanced Catheter Therapies ("ACT") is a commercialization stage medical device company with a targeted portfolio of technologies for the treatment of vascular disease. It is developing an innovative and highly proprietary vascular clearing and drug delivery system of catheters. Our lead device is the FDA cleared and patented Pressana Occlusion Perfusion Catheter or OPC. It is a universal targeted liquid drug delivery platform system. It is extremely versatile able to precisely deliver most any physician selected agents into the periphery with little to no systemic release of the agent.